- Pulse Biosciences Announces Timing of Rights Offering for Up to $60,000,000
- Pulse Biosciences Schedules First Quarter 2024 Financial Results Conference Call for May 7, 2024
- Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results
- Pulse Biosciences Announces Plans to Initiate a Rights Offering
- Pulse Biosciences Schedules Fourth Quarter & Full Year 2023 Financial Results Conference Call for March 28, 2024
- Pulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode System
- Pulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for Initial Patients treated in the CellFX® nsPFA™ 360° Cardiac Catheter First-in-Human Feasibility Study
More ▼
Key statistics
As of last trade, Pulse Biosciences Inc (PLSE:NAQ) traded at 8.09, 114.02% above the 52 week low of 3.78 set on Oct 26, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 7.71 |
---|---|
High | 8.13 |
Low | 7.52 |
Bid | 8.09 |
Offer | 8.14 |
Previous close | 7.60 |
Average volume | 133.82k |
---|---|
Shares outstanding | 55.23m |
Free float | 16.36m |
P/E (TTM) | -- |
Market cap | 419.71m USD |
EPS (TTM) | -0.8936 USD |
Data delayed at least 15 minutes, as of May 02 2024 18:19 BST.
More ▼